In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. SparkRx is a self-guided therapy program for teens run entirely on
NextGen Venture Partners, a young, Washington, D.C.-based venture firm that’s quarterbacked by a handful of investors but fueled financially by a network of hundreds of part-time investors wh